L1 Health is looking to develop industry leading platforms that transform healthcare. We partner with entrepreneurs and industry executives to identify and invest in creative ideas that take advantage of powerful, long-term global trends and have the potential to change healthcare and improve lives. We understand the time and operational focus required to achieve success. With over $3bn in evergreen capital, L1 Health can dedicate the time it takes to build industry leaders, invest throughout the economic cycle, and tailor its approach to each opportunity – from minority stakes to majority control, from start-up companies to industry leaders.
“In 2024, L1 Health’s strategic focus on strengthening and scaling its portfolio companies delivered robust results across its diverse healthcare holdings. By fostering operational excellence and targeted investment, L1 Health propelled four key platforms - Remedica, Sun Wave Group, K2 HealthVentures and Destination Pet - to new heights.”
Looking back on a year of resilience, ingenuity and achievement.
2024 year in review - L1 Health
Net assets under management (31 Dec 2024)